Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Learn effective ways to make fast cash while working from home. These tips can help you enhance your income quickly.
28,086 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
AI relies on chips to power today’s breakthroughs. This article uncovers a less-prominent semiconductor ETF idea, why...
A top OpenAI robotics executive has resigned amid concerns over guardrails for a Pentagon AI deal. The move signals t...
Southeast Asia confronts a growing gap in the AI hardware value chain as global demand for AI chips climbs. Governmen...
Fidelity’s zero-fee ETF has quietly tracked broad-market gains for years, delivering competitive returns with no expe...
A prominent SaaS executive warns that AI could erode long-standing moats, while industry data show enduring protectio...
Jet fuel prices are climbing as Middle East tensions tighten oil supply, prompting airlines to consider fare increase...
A landmark joint interpretive guidance from the SEC and CFTC clarifies crypto regulation, focusing on security classi...
If you’re chasing growth in a shifting market, two popular choices sit on opposite ends of the spectrum: MGK for mega...
A federal judge blocked the Trump administration from labeling Anthropic a supply chain risk, calling the move a poss...
A $1 million 401(K) balance can still bring big tax and Medicare costs. Here are five actionable moves to protect you...
A fresh, per-capita violence ranking shifts attention away from familiar conflict zones, signaling new risk dynamics ...